Philippines Meningitis Vaccine Market Research Report 2018

April 2018 | 101 pages | ID: P893E7F4022EN
QYResearch

Abstracts

The global Meningitis Vaccine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Philippines plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Meningitis Vaccine development status and future trend in Philippines, focuses on top players in Philippines, also splits Meningitis Vaccine by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Philippines market include

• GlaxoSmithKline
• Baxter International
• Sanofi Pasteur
• Merck
• Novartis
• Pfizer
• Hualan
• Zhejiang Tianyuan
• Beijing Tiantan Biological

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Meningitis A+C
• Meningitis ACWY135
• Meningitis B

On the basis of the end users/Application, this report covers

• Medical Care
• Healthy
• Hospital

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Philippines Meningitis Vaccine Market Research Report 2018

1 MENINGITIS VACCINE OVERVIEW

1.1 Product Overview and Scope of Meningitis Vaccine
1.2 Classification of Meningitis Vaccine by Product Category
  1.2.1 Philippines Meningitis Vaccine Sales (K Doses) Comparison by Type (2013-2025)
  1.2.2 Philippines Meningitis Vaccine Sales (K Doses) Market Share by Type in 2017
  1.2.3 Meningitis A+C
  1.2.4 Meningitis ACWY135
  1.2.5 Meningitis B
1.3 Philippines Meningitis Vaccine Market by Application/End Users
  1.3.1 Philippines Meningitis Vaccine Sales (K Doses) and Market Share Comparison by Application (2013-2025)
  1.3.2 Medical Care
  1.3.3 Healthy
  1.3.4 Hospital
1.4 Philippines Revenue and Sales of Meningitis Vaccine (2013-2025)
  1.4.1 Philippines Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2025)
  1.4.2 Philippines Meningitis Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 PHILIPPINES MENINGITIS VACCINE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Philippines Meningitis Vaccine Sales (K Doses) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Philippines Meningitis Vaccine Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Philippines Meningitis Vaccine Average Price (USD/Dose) by Players/Manufacturers (2013-2018)
2.4 Philippines Meningitis Vaccine Market Competitive Situation and Trends
  2.4.1 Philippines Meningitis Vaccine Market Concentration Rate
  2.4.2 Philippines Meningitis Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Philippines Market
2.5 Philippines Players/Manufacturers Meningitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 PHILIPPINES MENINGITIS VACCINE SALES AND REVENUE (VALUE) BY TYPE (2013-2018)

3.1 Philippines Meningitis Vaccine Sales (K Doses) and Market Share by Type/ Product Category (2013-2018)
3.2 Philippines Meningitis Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Philippines Meningitis Vaccine Price (USD/Dose) by Type (2013-2018)
3.4 Philippines Meningitis Vaccine Sales Growth Rate (%) by Type (2013-2018)

4 PHILIPPINES MENINGITIS VACCINE SALES BY APPLICATION (2013-2018)

4.1 Philippines Meningitis Vaccine Sales (K Doses) and Market Share by Application (2013-2018)
4.2 Philippines Meningitis Vaccine Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 PHILIPPINES MENINGITIS VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

5.1 GlaxoSmithKline
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Meningitis Vaccine Product Category, Application and Specification
    5.1.2.1 Product A
    5.1.2.2 Product B
  5.1.3 GlaxoSmithKline Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.1.4 Main Business/Business Overview
5.2 Baxter International
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Meningitis Vaccine Product Category, Application and Specification
    5.2.2.1 Product A
    5.2.2.2 Product B
  5.2.3 Baxter International Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.2.4 Main Business/Business Overview
5.3 Sanofi Pasteur
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Meningitis Vaccine Product Category, Application and Specification
    5.3.2.1 Product A
    5.3.2.2 Product B
  5.3.3 Sanofi Pasteur Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.3.4 Main Business/Business Overview
5.4 Merck
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Meningitis Vaccine Product Category, Application and Specification
    5.4.2.1 Product A
    5.4.2.2 Product B
  5.4.3 Merck Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.4.4 Main Business/Business Overview
5.5 Novartis
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Meningitis Vaccine Product Category, Application and Specification
    5.5.2.1 Product A
    5.5.2.2 Product B
  5.5.3 Novartis Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.5.4 Main Business/Business Overview
5.6 Pfizer
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Meningitis Vaccine Product Category, Application and Specification
    5.6.2.1 Product A
    5.6.2.2 Product B
  5.6.3 Pfizer Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.6.4 Main Business/Business Overview
5.7 Hualan
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Meningitis Vaccine Product Category, Application and Specification
    5.7.2.1 Product A
    5.7.2.2 Product B
  5.7.3 Hualan Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.7.4 Main Business/Business Overview
5.8 Zhejiang Tianyuan
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Meningitis Vaccine Product Category, Application and Specification
    5.8.2.1 Product A
    5.8.2.2 Product B
  5.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.8.4 Main Business/Business Overview
5.9 Beijing Tiantan Biological
  5.9.1 Company Basic Information, Manufacturing Base and Competitors
  5.9.2 Meningitis Vaccine Product Category, Application and Specification
    5.9.2.1 Product A
    5.9.2.2 Product B
  5.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  5.9.4 Main Business/Business Overview

6 MENINGITIS VACCINE MANUFACTURING COST ANALYSIS

6.1 Meningitis Vaccine Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Meningitis Vaccine

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Meningitis Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Meningitis Vaccine Major Manufacturers in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 PHILIPPINES MENINGITIS VACCINE MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

10.1 Philippines Meningitis Vaccine Sales (K Doses), Revenue (Million USD) Forecast (2018-2025)
10.2 Philippines Meningitis Vaccine Sales (K Doses) Forecast by Type (2018-2025)
10.3 Philippines Meningitis Vaccine Sales (K Doses) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Philippines Market Size (Million USD) Status and Outlook (2013-2025)
Table Meningitis Vaccine Sales (K Doses) and Revenue (Million USD) Market Split by Product Type
Table Meningitis Vaccine Sales (K Doses) by Application (2017-2025)
Figure Product Picture of Meningitis Vaccine
Table Philippines Meningitis Vaccine Sales (K Doses) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Philippines Meningitis Vaccine Sales Volume Market Share by Type in 2017
Figure Meningitis A+C Product Picture
Figure Meningitis ACWY135 Product Picture
Figure Meningitis B Product Picture
Figure Philippines Meningitis Vaccine Sales (K Doses) Comparison by Application (2013-2025)
Figure Philippines Sales Market Share (%) of Meningitis Vaccine by Application in 2017
Figure Medical Care Examples
Figure Healthy Examples
Figure Hospital Examples
Figure Philippines Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2025)
Figure Philippines Meningitis Vaccine Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Philippines Meningitis Vaccine Sales of Key Players/Manufacturers (2013-2018)
Table Philippines Meningitis Vaccine Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Philippines Meningitis Vaccine Sales Share (%) by Players/Manufacturers
Figure 2017 Philippines Meningitis Vaccine Sales Share (%) by Players/Manufacturers
Table Philippines Meningitis Vaccine Revenue by Players/Manufacturers (2013-2018)
Table Philippines Meningitis Vaccine Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Philippines Meningitis Vaccine Revenue Share (%) by Players/Manufacturers
Figure 2017 Philippines Meningitis Vaccine Revenue Share (%) by Players/Manufacturers
Table Philippines Market Meningitis Vaccine Average Price (USD/Dose) of Key Players/Manufacturers (2013-2018)
Figure Philippines Market Meningitis Vaccine Average Price (USD/Dose) of Key Players/Manufacturers in 2017
Figure Philippines Meningitis Vaccine Market Share of Top 3 Players/Manufacturers
Figure Philippines Meningitis Vaccine Market Share of Top 5 Players/Manufacturers
Table Philippines Players/Manufacturers Meningitis Vaccine Manufacturing Base Distribution and Sales Area
Table Philippines Players/Manufacturers Meningitis Vaccine Product Category
Table Philippines Meningitis Vaccine Sales (K Doses) by Type (2013-2018)
Table Philippines Meningitis Vaccine Sales Share (%) by Type (2013-2018)
Figure Philippines Meningitis Vaccine Sales Share (%) by Type (2013-2018)
Figure Philippines Meningitis Vaccine Sales Market Share (%) by Type in 2017
Table Philippines Meningitis Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Philippines Meningitis Vaccine Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Meningitis Vaccine by Type (2013-2018)
Figure Revenue Market Share of Meningitis Vaccine by Type in 2017
Table Philippines Meningitis Vaccine Price (USD/Dose) by Type (2013-2018)
Figure Philippines Meningitis Vaccine Sales Growth Rate (%) by Type (2013-2018)
Table Philippines Meningitis Vaccine Sales (K Doses) by Application (2013-2018)
Table Philippines Meningitis Vaccine Sales Market Share (%) by Application (2013-2018)
Figure Philippines Meningitis Vaccine Sales Market Share (%) by Application (2013-2018)
Figure Philippines Meningitis Vaccine Sales Market Share (%) by Application in 2017
Table Philippines Meningitis Vaccine Sales Growth Rate (%) by Application (2013-2018)
Figure Philippines Meningitis Vaccine Sales Growth Rate (%) by Application (2013-2018)
Table GlaxoSmithKline Meningitis Vaccine Basic Information List
Table GlaxoSmithKline Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure GlaxoSmithKline Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Baxter International Meningitis Vaccine Basic Information List
Table Baxter International Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Baxter International Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Baxter International Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Baxter International Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Sanofi Pasteur Meningitis Vaccine Basic Information List
Table Sanofi Pasteur Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Sanofi Pasteur Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Sanofi Pasteur Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Sanofi Pasteur Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Merck Meningitis Vaccine Basic Information List
Table Merck Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Merck Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Merck Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Merck Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Novartis Meningitis Vaccine Basic Information List
Table Novartis Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Novartis Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Novartis Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Novartis Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Pfizer Meningitis Vaccine Basic Information List
Table Pfizer Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Pfizer Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Pfizer Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Pfizer Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Hualan Meningitis Vaccine Basic Information List
Table Hualan Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Hualan Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Hualan Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Hualan Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Zhejiang Tianyuan Meningitis Vaccine Basic Information List
Table Zhejiang Tianyuan Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Zhejiang Tianyuan Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Zhejiang Tianyuan Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Zhejiang Tianyuan Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Beijing Tiantan Biological Meningitis Vaccine Basic Information List
Table Beijing Tiantan Biological Meningitis Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Beijing Tiantan Biological Meningitis Vaccine Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Beijing Tiantan Biological Meningitis Vaccine Sales Market Share (%) in Philippines (2013-2018)
Figure Beijing Tiantan Biological Meningitis Vaccine Revenue Market Share (%) in Philippines (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningitis Vaccine
Figure Manufacturing Process Analysis of Meningitis Vaccine
Figure Meningitis Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Meningitis Vaccine Major Players/Manufacturers in 2017
Table Major Buyers of Meningitis Vaccine
Table Distributors/Traders List
Figure Philippines Meningitis Vaccine Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Philippines Meningitis Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Philippines Meningitis Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table Philippines Meningitis Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure Philippines Meningitis Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure Philippines Meningitis Vaccine Sales Volume Market Share Forecast by Type in 2025
Table Philippines Meningitis Vaccine Sales (K Doses) Forecast by Application (2018-2025)
Figure Philippines Meningitis Vaccine Sales Volume Market Share Forecast by Application (2018-2025)
Figure Philippines Meningitis Vaccine Sales Volume Market Share Forecast by Application in 2025